Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more) This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Insmed Inc INSM

Healthcare Biotechnology
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination... see more

Current News (NDAQ:INSM)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 26, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 25, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 24, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 23, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 21, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

GlobeNewswire January 20, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 18, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

ACCESS Newswire January 16, 2026
View More News ››

Opinion & Analysis (NDAQ:INSM)

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Streetwise Reports February 4, 2020
View More Opinion ››

Bullboard Posts (NDAQ:INSM)

RE: Upcoming FDA decision on the approval of a sma

That's nice, but you're not talking about INSM. It's is scheduled for 06/26.Please stop spamming for a not free financial rag
mornings1 - June 23, 2009

NEWS RELEASE

Momenta, Insmed May Gain From Biotech Generics Law (Update1) By Catherine Larkin March 27 (Bloomberg) -- Momenta...
sebaxter - March 27, 2008

Investor Fact Sheet with Updates

Insmed Inc. Releases Investor Fact Sheet with Updates on Drug Development Progress RICHMOND, Va., Apr 25, 2007 (BUSINESS WIRE...
scissors14 - April 30, 2007

down to 80 cents this AM

I keep looking at this stock. It was down as low as 80 cents and closed at 87. They lost the infringment case to TRCA and DNA, but have...
jamieb3 - December 26, 2006

Impressive Launch....C.E.Unterberg, Towbin

Impressive Launch....C.E.Unterberg, Towbin Insmed, Inc. (INSM5,6,7,8,9 $1.18) Buy 2Q:06 Results - Impressive Launch "We...
scissors14 - September 4, 2006

Insmed Wins Court Case

Court Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against Insmed RICHMOND, Va., Jun 13, 2006 (BUSINESS WIRE)...
scissors14 - June 13, 2006
View more Bullboard ››

Nine Mile Metals Ltd.

Nine Mile Metals Ltd.

Nine Mile Metals Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. The company ...
View More »

Podcasts